Resveratrol for rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Infections, Skin clinical trials.
This study tests whether resveratrol (a natural substance found in grapes) can help control moderate-to-high rheumatoid arthritis when added to your current RA medications. It aims to see if it reduces disease activity safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You need a firm rheumatoid arthritis (RA) diagnosis and moderate-to-high disease activity (like joint pain and swelling).
- You are already taking at least one stable RA medication (such as methotrexate) for the past 3 months.
- You cannot be on biologic treatments, other anti-inflammatory drugs, or antioxidants.
- You must not have other serious health issues like cancer, liver/kidney disease, or be a smoker or pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding silymarin (a natural supplement from milk thistle) to standard methotrexate treatment can improve symptoms of rheumatoid arthritis. It may help reduce joint pain and swelling for people who are not yet in remission.
This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
This trial tests whether two natural plant-based medicines (diosmin and hesperidin) can reduce symptoms in people with mild to moderate rheumatoid arthritis. It compares treatment outcomes to standard care to see if these supplements help control the disease.
This study tests whether increasing the dose of methotrexate or switching from pills to injections can better control rheumatoid arthritis symptoms. It aims to find the best way to use this common medication to reduce joint pain and swelling.
This study tests a new investigational drug called SR-878 for people with rheumatoid arthritis. It aims to see if the drug is safe and tolerable. You may join if you are between 18 and 60, have RA for at least 3 months, and take a stable dose of methotrexate.
Hear when a new Rheumatic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.